BBOT
BridgeBio Oncology Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.98
+0.90%Aug 11, 2026, 20:05 UTC
BridgeBio Oncology Therapeutics reported financial results for the second quarter ended June 30, 2026, and provided a business update.
Source: